launch country fund went different collaboration gv force countries cases shows safe seeks govt drug doses astrazeneca trial submit vaccination world research phase sec expected 1st task available rainbow seeking

Articles for Rdif, search results for kirill

Serum Institute to produce Russia’s Sputnik V vaccine
3 years, 5 months ago

Serum Institute to produce Russia’s Sputnik V vaccine

The Hindu  

Serum Institute of India will be producing atleast 300 million doses of Sputnik V a year, with the first batch of the Russian vaccine against Covid-19 from its facility likely to be rolled out in September. These details emerged with the Russia’s sovereign wealth fund RDIF on Tuesday announcing a collaboration with the vaccine maker to manufacture Sputnik V for …

India Russia Serum Serum Institute Of India Serum Institute Rdif Sputnik V
Serum Institute to start production of Sputnik V vaccine in India from September
3 years, 5 months ago

Serum Institute to start production of Sputnik V vaccine in India from September

India Today  

The Russian Direct Investment Fund, Russia’s sovereign wealth fund, and Serum Institute of India have announced plans to start the production of the Sputnik V vaccine in India. The first batch of Sputnik V vaccine is expected to be produced at the Serum Institute’s facilities starting September. Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said, “RDIF is delighted …

India Institute Russian Vaccine Sputnik Serum Institute Of India Serum Institute
Sputnik V vaccine effective against Covid variants including Delta, claims study
3 years, 5 months ago

Sputnik V vaccine effective against Covid variants including Delta, claims study

India Today  

Russian-made Sputnik V vaccine is effective against new variants of Covid-19, a study now claims. READ: Single dose of Sputnik V vaccine enough for recovered Covid-19 patients: Study In a statement on Monday, RDIF CEO Kirill Dmitriev said, "Sputnik V pioneered the vaccine cocktail approach with two shots. Sputnik V vaccine being administered at a vaccination centre in Gurugram on …

Research Variants Covid Russian Study New Strains Sputnik
RDIF, Panacea Biotec launch production of Sputnik V vaccine in India; set to produce 10 mn doses per year
3 years, 7 months ago

RDIF, Panacea Biotec launch production of Sputnik V vaccine in India; set to produce 10 mn doses per year

Firstpost  

The first batch of the COVID-19 vaccine produced at Panacea Biotec’s facilities at Baddi in Himachal Pradesh will be shipped to Russia’s Gamaleya Center for quality control New Delhi: The Russian Direct Investment Fund and Indian drug firm Panacea Biotec on Monday announced the launch of the production of the Sputnik V coronavirus vaccine in India. The first batch of …

India Russia Production Vaccine Panacea Biotec Panacea Biotec
RDIF, Panacea Biotec start Sputnik V Covid vaccine production in India
3 years, 7 months ago

RDIF, Panacea Biotec start Sputnik V Covid vaccine production in India

India Today  

The Russian Direct Investment Fund has started the production of 'Sputnik V' Covid-19 vaccine in India in collaboration with domestic pharma major Panacea Biotec. The joint venture is going to produce 100 million doses per year of Sputnik V in India and is expected to undergo full-scale production this summer, a joint statement issued on Monday said. "Launch of production …

India Russia Production Covid Vaccine Panacea Biotec Sputnik
Covid 19 Vaccine: Russian Sputnik V on CoWin app, check price and other details
3 years, 7 months ago

Covid 19 Vaccine: Russian Sputnik V on CoWin app, check price and other details

India Today  

The Russian COVID vaccine Sputnik V that became a part of India's vaccination drive on May 14 is now available on the country’s CoWin Portal. Sharing a picture of the vaccination drive in India, the official handle of Sputnik V tweeted "Start of #SputnikV vaccination at @HospitalsApoll facility in #India's Hyderabad." RDIF has planned to start the production of Sputnik …

India Hyderabad Russia Price Russian Available Covid Vaccine
Russia's Sputnik V Covid Vaccine Found to be Over 91% Effective, Expects India Approval Soon
3 years, 10 months ago

Russia's Sputnik V Covid Vaccine Found to be Over 91% Effective, Expects India Approval Soon

News 18  

India is expected to grant emergency use authorization for Russia’s Sputnik V COVID-19 vaccine this month or next, the Russian Direct Investment Fund, which markets the shot abroad, told Indian news agency ANI on Tuesday. India is a key partner in terms of production of vaccine and we expect that there’ll be a restricted emergency use order for the Sputnik …

India Russia Indian Vaccine Sputnik Rdif Emergency Use
India to produce over 300 million doses of Sputnik-V vaccine against coronavirus
4 years ago

India to produce over 300 million doses of Sputnik-V vaccine against coronavirus

India TV News  

India may produce around 300 million doses of Russia's Sputnik V coronavirus vaccine in 2021, says Kirill Dmitriev, CEO of Russian Direct Investment Fund. "The efficacy of the Sputnik V vaccine is 91.4 per cent, based on the final control point analysis of data obtained 21 days after administering the first dose," Gamaleya Center and the Russian Direct Investment Fund …

India Russia Cent Russian Produce Sputnik Rdif
Coronavirus vaccine Sputnik V 92% effective against COVID-19, claims Russia
4 years, 1 month ago

Coronavirus vaccine Sputnik V 92% effective against COVID-19, claims Russia

India TV News  

Sputnik V, Russia's experimental COVID-19 vaccine is 92% effective at protecting people from coronavirus, according to interim trial results, the Russian Direct Investment Fund said on Wednesday. The interim results are based on data from the first 16,000 trial participants to receive both shots of the two-dose vaccine, the country's sovereign wealth fund said. Russia's announcement follows swiftly on from …

Russia Coronavirus Covid Rdif Sputnik V Vaccine Sputnik
Sputnik V vaccine’s early efficacy trial data expected this month, says RDIF
4 years, 1 month ago

Sputnik V vaccine’s early efficacy trial data expected this month, says RDIF

Live Mint  

New Delhi: The Russian Direct Investment Fund on Monday said that it plans to release interim data from its efficacy trials of Sputnik V vaccine in its home country later this month. We also expect to publish interim efficacy data of Sputnik V clinical trials in November," RDIF chief executive officer Kirill Dmitriev said, while “welcoming” the successful interim efficacy …

Trial Vaccine Sputnik Rdif Efficacy Sputnik V Vaccine
Kremlin dismisses vaccine disinformation campaign accusations as ‘circus’
4 years, 2 months ago

Kremlin dismisses vaccine disinformation campaign accusations as ‘circus’

CNN  

Moscow CNN — Kremlin spokesperson Dmitry Peskov dismissed the reaction of the UK Foreign Secretary Dominic Raab to the Times report saying that Russia is engaging in a disinformation campaign to discredit the Oxford University coronavirus vaccine in an effort to promote its own vaccine Sputnik V, developed by the Gamaleya Institute. “Russia is not misinforming anyone, Russia proudly talks …

Russia Campaign Trials Disinformation Cnn Russian Kremlin
Covid vaccine will be available in India by November, awaiting clearance: Russian Fund CEO
4 years, 3 months ago

Covid vaccine will be available in India by November, awaiting clearance: Russian Fund CEO

India Today  

In an exclusive interview with India Today's consulting editor Rajdeep Sardesai, co-chairman and Managing Director of Dr Reddy's Laboratories GV Prasad and RDIF CEO Kirill Dmitriev shed light on his efforts to bring about a Covid-19 vaccine in India. CEO of RDIF, Kirill Dmitriev said, "We are confident India will play a vital role in fighting Covid-19 Make in India …

India Russia Covid Vaccine Rdif Our Vaccine Kirill Dmitriev Gv Prasad